Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and/or metformin for cognitive impairment in type 2 diabetes
ChiCTR-TCH-10001013Phase 4Completed
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Nov 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of pioglitazone, metformin and human insulin in type 2 diabetes mellitus (T2DM) and confusion (6 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: Evaluation of cognition. Started Nov 2018; status: completed.
02
Drugs
pioglitazonemetforminhuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)confusion
Beyond the preview
Go deeper on ChiCTR-TCH-10001013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TCH-10001013.